Company announcement no 2025-01
10 January 2025
Transactions with Demant shares by managers and closely related parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Søren Nielsen
2.
Reason for the notification
a)
Position/status
President & CEO
b)
Initial notification/amendment
Initial notification
3)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2024.
c)
Price(s) and volume(s)
Price(s) Volume(s)
Allocated shares from January until December 2024:
DKK 351.27 per share 299 shares
DKK 362.42 per share 289 shares
DKK 326.63 per share 321 shares
DKK 327.08 per share 331 shares
DKK 330.41 per share 328 shares
DKK 298.46 per share 363 shares
DKK 260.28 per share 416 shares
DKK 286.14 per share 379 shares
DKK 263.42 per share 411 shares
DKK 261.77 per share 414 shares
DKK 275.00 per share 394 shares
DKK 280.81 per share 386 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter.
d)
Aggregated information:
- Aggregated volume
- Price
Aggregated volume: 4,331 shares
Price: DKK 1,290,172.78
e)
Date of the transaction
8 January 2025
f)
Place of the transaction
Nasdaq Copenhagen A/S
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
René Schneider
2.
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/amendment
Initial notification
3)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2024.
c)
Price(s) and volume(s)
Price(s) Volume(s)
Allocated shares from January until December 2024:
DKK 351.27 per share 71 shares
DKK 362.42 per share 97 shares
DKK 326.63 per share 93 shares
DKK 327.08 per share 95 shares
DKK 330.41 per share 94 shares
DKK 298.46 per share 104 shares
DKK 260.28 per share 121 shares
DKK 286.14 per share 110 shares
DKK 263.42 per share 100 shares
DKK 261.77 per share 101 shares
DKK 275.00 per share 96 shares
DKK 280.81 per share 94 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter.
d)
Aggregated information:
- Aggregated volume
- Price
Aggregated volume: 1,176 shares
Price: DKK 352,068.76
e)
Date of the transaction
8 January 2025
f)
Place of the transaction
Nasdaq Copenhagen A/S
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Niels Wagner
2.
Reason for the notification
a)
Position/status
President of Hearing Care
b)
Initial notification/amendment
Initial notification
3)
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2024.
c)
Price(s) and volume(s)
Price(s) Volume(s)
Allocated shares from January until December 2024:
DKK 351.27 per share 173 shares
DKK 362.42 per share 167 shares
DKK 326.63 per share 187 shares
DKK 327.08 per share 198 shares
DKK 330.41 per share 196 shares
DKK 298.46 per share 217 shares
DKK 260.28 per share 249 shares
DKK 286.14 per share 226 shares
DKK 263.42 per share 246 shares
DKK 261.77 per share 247 shares
DKK 275.00 per share 235 shares
DKK 280.81 per share 231 shares
The share price corresponds to the prices of the allocated shares during the 8th day after the end of the respective month or on the next trading day hereafter.
d)
Aggregated information:
- Aggregated volume
- Price
Aggregated volume: 2,572 shares
Price: DKK 765,074.91
e)
Date of the transaction
8 January 2025
f)
Place of the transaction
Nasdaq Copenhagen A/S
Further information:
Peter Pudselykke, Head of Investor Relations
Maribel Alonso Francisco, Communication Advisor
Phone +45 3917 7300
www.demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
-
2025-01 Managers and closely related parties transactions with Demant shares.pdf
